The Inflation Reduction Act’s policy capping out-of-pocket costs for insulin to $35 for a month’s supply led to increases in the total number of insulin fills for Medicare beneficiaries, according to a new study from the USC Schaeffer Center for Health Policy & Economics and University of Wisconsin–Madison.
Manufacturing roundup: Curia secures deal with Touchlight; Gene-focused VectorBuilder hits ‘unicorn status’
CDMO Curia inked an agreement with Torchlight, a maker of its own enzymatic DNA that will now provide Curia with access to its ‘doggybone DNA,’
July 28, 2023